COVID-19 encephalopathy: detection of antibodies against SARS-CoV-2 in CSF

J Neurol. 2020 Oct;267(10):2810-2811. doi: 10.1007/s00415-020-09975-1. Epub 2020 Jun 11.

Daniela Andriuta¹, Pierre-Alexandre Roger², William Thibault³, Bénédicte Toublanc^{2

4}, Chloe Sauzay^{5

6}, Sandrine Castelain^{7

8}, Olivier Godefroy³, Etienne Brochot^{7

8}

¹ Department of Neurology and Laboratoire de Neurosciences Fonctionnelles et Pathologies (UR UPJV 4559), Amiens University Medical Center and Jules Verne University of Picardy, 80054, Amiens, France. andriuta.daniela@chu-amiens.fr.
² Department of Respiratory Intensive Care Unit and Lung Diseases, Amiens University Medical Center and Jules Verne University of Piacardy, Amiens, France.
³ Department of Neurology and Laboratoire de Neurosciences Fonctionnelles et Pathologies (UR UPJV 4559), Amiens University Medical Center and Jules Verne University of Picardy, 80054, Amiens, France.
⁴ Department of Pneumology, Amiens University Medical Center and INSERM U1088, Jules Verne University of Picardy, Amiens, France.
⁵ Department of Biochemistry, Amiens University Medical Center, Amiens, France.
⁶ CHIMERE Unit, EA7516, Jules Verne University of Picardie, Amiens, France.
⁷ Department of Virology, Amiens University Medical Center, Amiens, France.
⁸ AGIR Reaserch Unit ER4294, Jules Verne University of Picardie, Amiens, France.

No abstract available

Publication types